ResearcherCentro de Investigación Médica AplicadaActive in the last 2 years
Shruthi Narayanan
Matched on ORCID iD 0000-0003-1375-3637; OpenAlex author ID A5026112588. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2021: 1 paper · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper
Papers 3
- Quantitative evaluation of the role of the microenvironment in the phenotype, metabolism, and drug resistance of PDAC tumor organoids Co-author DOI 10.1101/2024.12.31.630904↗
- LAMC2 Regulates Key Transcriptional and Targetable Effectors to Support Pancreatic Cancer Growth. First author DOI 10.1158/1078-0432.ccr-22-0794↗
- PDAC as an Immune Evasive Disease: Can 3D Model Systems Aid to Tackle This Clinical Problem? Co-author DOI 10.3389/fcell.2021.787249↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Mariano Ponz‐Sarvisé · 3 shared papers, 2021–2025 · strength 0.61
- Paper Quantitative evaluation of the role of the microenvironment in the phenotype, metabolism, and drug resistance of PDAC t… DOI 10.1101/2024.12.31.630904↗
- Paper PDAC as an Immune Evasive Disease: Can 3D Model Systems Aid to Tackle This Clinical Problem? DOI 10.3389/fcell.2021.787249↗
- Paper LAMC2 Regulates Key Transcriptional and Targetable Effectors to Support Pancreatic Cancer Growth. DOI 10.1158/1078-0432.ccr-22-0794↗
- Silvestre Vicent · 3 shared papers, 2021–2025 · strength 0.61
- Paper Quantitative evaluation of the role of the microenvironment in the phenotype, metabolism, and drug resistance of PDAC t… DOI 10.1101/2024.12.31.630904↗
- Paper PDAC as an Immune Evasive Disease: Can 3D Model Systems Aid to Tackle This Clinical Problem? DOI 10.3389/fcell.2021.787249↗
- Paper LAMC2 Regulates Key Transcriptional and Targetable Effectors to Support Pancreatic Cancer Growth. DOI 10.1158/1078-0432.ccr-22-0794↗
- Ioritz Sorzabal-Bellido · 1 shared paper, 2025 · strength 0.25
- Carlos Ortíz-de-Solórzano · 1 shared paper, 2025 · strength 0.25
- Rodrigo Entrialgo‐Cadierno · 1 shared paper, 2023 · strength 0.14
- Marija Trajkovic‐Arsic · 1 shared paper, 2023 · strength 0.14
- Vincenzo Corbo · 1 shared paper, 2023 · strength 0.14
- Oihane Erice · 1 shared paper, 2023 · strength 0.14
- Pietro Delfino · 1 shared paper, 2023 · strength 0.14
- Antonia Malinova · 1 shared paper, 2023 · strength 0.14
- Jens Thomas Siveke · 1 shared paper, 2023 · strength 0.14
- Aldo Scarpa · 1 shared paper, 2023 · strength 0.14
- Daniel Öhlund · 1 shared paper, 2023 · strength 0.14
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.